Companies Dominating the Blastomycosis Treatment Landscape
- Emcure Pharmaceuticals Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Viatris Inc.
- Hindustan Antibiotics Limited
- Sun Pharmaceutical Industries Ltd.
- Novartis AG
- Sanofi-aventis Groupe
- Abbott Laboratories
- Merck & Co., Inc.
- Siemens Healthcare GmbH
- Pfizer Inc.
Browse Key Market Insights with Data Illustration:
In the News
-
Viatris Inc. acquired Oyster Point Pharma and Famy Life Sciences, to establish a franchise for ophthalmology.
-
Sun Pharmaceutical Industries Ltd. obtained US FDA clearance for Amphotericin B injection. Further, Amphotericin B is an antifungal drug used to treat leishmaniasis and severe fungal infections, such as mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
